Immune Mediators Regulate CFTR Expression through a Bifunctional Airway-Selective Enhancer

Molecular and Cellular Biology

Volumn 33, Issue 15, 2013, Pages 2843-2853

  Zhang, Zhaolin ^a   Leir, Shih Hsing ^a   Harris, Ann ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; INTERFERON REGULATORY FACTOR 1; INTERFERON REGULATORY FACTOR 2; NUCLEAR FACTOR Y; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BASE SEQUENCE; BRONCHI; CCAAT-BINDING FACTOR; CELL LINE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DEOXYRIBONUCLEASE I; ENHANCER ELEMENTS, GENETIC; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HISTONES; HUMANS; INTERFERON REGULATORY FACTOR-1; REPRESSOR PROTEINS;

EID: 84880675359     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00003-13     Document Type: Article

References (53)

1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J-L, Drumm ML, Iannuzzi MC, Collins FS, Tsui L-C. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066-1073.
2. Trezise AEO, Chambers JA, Wardle CJ, Gould S, Harris A. 1993. Expression of the cystic fibrosis gene in human foetal tissues. Hum. Mol. Genet. 2:213-218.
3. Kreda SM, Mall M, Mengos A, Rochelle L, Yankaskas J, Riordan JR, Boucher RC. 2005. Characterization of wild-type and F508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol. Biol. Cell 16:2154-2167.
4. Ott CJ, Blackledge NP, Kerschner JL, Leir S-H, Crawford GE, Cotton CU, Harris A. 2009. Intronic enhancers coordinate epithelial-specific looping of the active CFTR locus. Proc. Natl. Acad. Sci. U. S. A. 106: 19934-19939.
5. Koh J, Sferra TJ, Collins FS. 1993. Characterization of the cystic fibrosis transmembrane conductance regulator promoter region. Chromatin context and tissue-specificity. J. Biol. Chem. 268:15912-15921.
6. Yoshimura K, Nakamura H, Trapnell BC, Dalemans W, Pavirani A, Lecocq JP, Crystal RG. 1991. The cystic fibrosis gene has a "housekeeping" type promoter and is expressed at low levels in cells of epithelial origin. J. Biol. Chem. 266:9140-9144.
7. Ott CJ, Blackledge NP, Leir S-H, Harris A. 2009. Novel regulatory mechanisms for the CFTR gene. Biochem. Soc. Trans. 37:843-848.
8. Ott CJ, Harris A. 2011. Genomic approaches for the discovery of CFTR regulatory elements. Transcription 2:23-27.
9. Gillen AE, Harris A. 2012. Transcriptional regulation of CFTR gene expression. Front. Biosci. (Elite ed) 4:587-592.
10. Smith AN, Barth ML, McDowell TL, Moulin DS, Nuthall HN, Hollingsworth MA, Harris A. 1996. A regulatory element in intron 1 of the cystic fibrosis transmembrane conductance regulator gene. J. Biol. Chem. 271:9947-9954.
11. Ott CJ, Suszko M, Blackledge NP, Wright JE, Crawford GE, Harris A. 2009. A complex intronic enhancer regulates expression of the CFTR gene by direct interaction with the promoter. J. Cell. Mol. Med. 13:680-692.
12. Kerschner JL, Harris A. 2012. Transcriptional networks driving enhancer function in the CFTR gene. Biochem. J. 446:203-212.
13. Gheldof N, Smith EM, Tabuchi TM, Koch CM, Dunham I, Stamatoyannopoulos JA, Dekker J. 2010. Cell-type-specific long-range looping interactions identify distant regulatory elements of the CFTR gene. Nucleic Acids Res. 38:4325-4336.
14. Zhang Z, Ott CJ, Lewandowska MA, Leir S-H, Harris A. 2012. Molecular mechanisms controlling CFTR gene expression in the airway. J. Cell. Mol. Med. 16:1321-1330.
15. Zhou VW, Goren A, Bernstein BE. 2011. Charting histone modifications and the functional organization of mammalian genomes. Nat. Rev. Genet. 12:7-18.
16. Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, Gruenert DC. 1994. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 10:38-47.
17. Fogh J, Fogh JM, Orfeo T. 1977. One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J. Nat. Cancer Inst. 59:221-226.
18. - secretion. Am. J. Physiol. 266:L493-L501.
19. Fogh J, Wright WC, Loveless JD. 1977. Absence of hela cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. 58:209-214.
20. Phylactides M, Rowntree R, Nuthall H, Ussery D, Wheeler A, Harris A. 2002. Evaluation of potential regulatory elements identified as DNase I hypersensitive sites in the CFTR gene. Eur. J. Biochem. 269:553-559.
21. Mouchel N, Henstra SA, McCarthy VA, Williams SH, Phylactides M, Harris A. 2004. HNF1α is involved in tissue-specific regulation of CFTR gene expression. Biochem. J. 378:909-918.
22. Blackledge NP, Carter EJ, Evans JR, Lawson V, Rowntree RK, Harris A. 2007. CTCF mediates insulator function at the CFTR locus. Biochem. J. 408:267-275.
23. Mouchel N, Broackes-Carter F, Harris A. 2003. Alternative 5'exons of the CFTR gene show developmental regulation. Hum. Mol. Genet. 12: 759-769.
24. Yigit E, Bischof JM, Zhang Z, Ott CJ, Kerschner JL, Leir S-H, Buitrago- Delgado E, Zhang Q, Wang J-PZ, Widom J, Harris A. 2013. Nucleosome mapping across the CFTR locus identifies novel regulatory factors. Nucleic Acids Res. 41:2857-2868.
25. Donati G, Gatta R, Dolfini D, Fossati A, Ceribelli M, Mantovani R. 2008. An NF-Y-dependent switch of positive and negative histone methyl marks on CCAAT promoters. PLoS One 3:e2066. doi:10.1371/journal.pone.0002066.
26. Gatta R, Mantovani R. 2008. NF-Y substitutes H2A-H2B on active cellcycle promoters: recruitment of CoREST-KDM1 and fine-tuning of H3 methylations. Nucleic Acids Res. 36:6592-6607.
27. Mantovani R. 1999. The molecular biology of the CCAAT-binding factor NF-Y. Gene 239:15-27.
28. Hatamochi A, Golumbek PT, Vanschaftingen E, Decrombrugghe B. 1988. A CCAAT DNA-binding factor consisting of two different components that are both required for DNA-binding. J. Biol. Chem. 263:5940-5947.
29. Kim IS, Sinha S, deCrombrugghe B, Maity SN. 1996. Determination of functional domains in the C subunit of the CCAAT-binding factor (CBF) necessary for formation of a CBF-DNA complex: CBF-B interacts simultaneously with both the CBF-A and CBF-C subunits to form a heterotrimeric CBF molecule. Mol. Cell. Biol. 16:4003-4013.
30. Dolfini D, Gatta R, Mantovani R. 2012. NF-Y and the transcriptional activation ofCCAATpromoters. Crit. Rev. Biochem. Mol. Biol. 47:29-49.
31. Tanaka N, Kawakami T, Taniguchi T. 1993. Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol. Cell. Biol. 13:4531-4538.
32. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. 2001. IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-655.
33. LohoffM, Mak TW. 2005. Roles of interferon-regulatory factors in Thelper-cell differentiation. Nat. Rev. Immunol. 5:125-135.
34. Wang Y, Liu D-P, Chen P-P, Koeffler HP, Tong X-J, Xie D. 2007. Involvement of IFN regulatory factor (IRF)-1 and IRF-2 in the formation and progression of human esophageal cancers. Cancer Res. 67:2535-2543.
35. Harada H, Fujita T, Miyamoto M, Kimura Y, Maruyama M, Furia A, Miyata T, Taniguchi T. 1989. Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 58:729-739.
36. Harada H, Willison K, Sakakibara J, Miyamoto M, Fujita T, Taniguchi T. 1990. Absence of the type I IFN system in EC cells: transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated. Cell 63:303-312.
37. Shiraga T, Winpenny JP, Carter EJ, McCarthy VA, Hollingsworth MA, Harris A. 2005. MZF-1 and DbpA interact with DNase I hypersensitive sites that correlate with expression of the human MUC1 mucin gene. Exp. Cell Res. 308:41-52.
38. Nagy L, Kao H-Y, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89: 373-380.
39. Roopra A, Sharling L, Wood IC, Briggs T, Bachfischer U, Paquette AJ, Buckley NJ. 2000. Transcriptional repression by neuron-restrictive silencer factor is mediated via the Sin3-histone deacetylase complex. Mol. Cell. Biol. 20:2147-2157.
40. Vo N, Goodman RH. 2001. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276:13505-13508.
41. Besancon F, Przewlocki G, Baro I, Hongre AS, Escande D, Edelman A. 1994. Interferon-gamma downregulates CFTR gene expression in epithelial cells. Am. J. Physiol 267:C1398-C1404.
42. Nakamura H, Yoshimura K, Bajocchi G, Trapnell BC, Pavirani A, Crystal RG. 1992. Tumor necrosis factor modulation of expression of the cystic fibrosis transmembrane conductance regulator gene. FEBS Lett. 314:366-370.
43. Kulka M, Dery R, Nahirney D, Duszyk M, Befus AD. 2005. Differential regulation of cystic fibrosis transmembrane conductance regulator by interferon γ in mast cells and epithelial cells. J. Pharmacol. Exp. Ther. 315: 563-570.
44. Tamura T, Yanai H, Savitsky D, Taniguchi T. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26:535-584.
45. Savitsky D, Tamura T, Yanai H, Taniguchi T. 2010. Regulation of immunity and oncogenesis by the IRF transcription factor family. Cancer Immunol. Immunother. 59:489-510.
46. Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M, Taniguchi T. 1993. Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2. Science 259:971-974.
47. Abdollahi A, Lord K, Hoffman-Liebermann B, Liebermann D. 1991. Interferon regulatory factor 1 is a myeloid differentiation primary response gene induced by interleukin 6 and leukemia inhibitory factor: role in growth inhibition. Cell Growth Differ. 2:401-407.
48. Bischof JM, Ott CJ, Leir S-H, Gosalia N, Song L, London D, Furey TS, Cotton CU, Crawford GE, Harris A. 2012. A genome-wide analysis of open chromatin in human tracheal epithelial cells reveals novel candidate regulatory elements for lung function. Thorax 67:385-391.
49. Baxevanis AD, Arents G, Moudrianakis EN, Landsman D. 1995. A variety of DNA-binding and multimeric proteins contain the histone fold motif. Nucleic Acids Res. 23:2685-2691.
50. Romier C, Cocchiarella F, Mantovani R, Moras D. 2003. The NF-YB/NF-YC structure gives insight into DNA binding and transcription regulation by CCAAT factor NF-Y. J. Biol. Chem. 278:1336-1345.
51. Ramachandran S, Karp PH, Jiang P, Ostedgaard LS, Walz AE, Fisher JT, Keshavjee S, Lennox KA, Jacobi AM, Rose SD, Behlke MA, Welsh MJ, Xing Y, McCray PB. 2012. A microRNA network regulates expression and biosynthesis of wild-type and F508 mutant cystic fibrosis transmembrane conductance regulator. Proc. Natl. Acad. Sci. U. S. A. 109:13362-13367.
52. De Amicis F, Giordano F, Vivacqua A, Pellegrino M, Panno ML, Tramontano D, Fuqua SAW, Andò S. 2011. Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor α gene expression via p38MAPK/CK2 signaling in human breast cancer cells. FASEB J. 25:3695-3707.
53. Yang L, Mei Q, Zielinska-Kwiatkowska A, Matsui Y, Blackburn ML, Benedetti D, Krumm AA, Taborsky GJ, Chansky HA. 2003. An ERG (ETS-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription corepressors mSin3A/B. Biochem. J. 369:651-657.